Eight Roads Ventures
VC Fund
London, United Kingdom
Eight Roads Ventures is a global venture capital firm managing $11bn of assets across offices in the UK, China, India, Japan, and the US. Together with our associated funds, including our US sister fund F-Prime Capital, our 50-year history of investing includes partnerships with over 500 companies such as Alibaba, AppsFlyer, Chewy, Fareye, Fever,Flywire, Fireblocks, Funnel.io, Gloat, Hibob, Icertis, Neo4j, Otrium, Owkin, Paidy, Spendesk, Tibber, Toast, Wallapop and Xoom.
- Total investments:
- 385
- Last investment:
- Lead investor:
- 41%
- Fund size:
- $350M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Eight Roads Ventures invests in
Stages Eight Roads Ventures invests in
Countries Eight Roads Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $6.5M–$62M
- Series B
- $8.5M–$85M
- Series C
- $15M–$118M
Investment Focus
Industry
- Software 54 (14%)
- Health Care 53 (14%)
- Information Technology 45 (12%)
- Biotechnology 43 (11%)
- Medical 31 (8%)
Stage
- Series B 114 (30%)
- Series A 89 (23%)
- Series C 59 (15%)
- Funding Round 28 (7%)
- Series D 22 (6%)
Country
- United States 81 (21%)
- China 52 (14%)
- India 31 (8%)
- Japan 24 (6%)
- United Kingdom 24 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Aditya Systla
Partner
|
Partner | Total investments: 12 | Find email | |
Gordon Zhang
Vice President & Principal
|
Vice President & Principal | Total investments: 1 | Find email | |
Jarlon Tsang
Managing Partner, Head of China
|
Managing Partner, Head of China | Total investments: 1 | Find email | |
Michael Treskow
Partner
|
Partner | Total investments: 13 | Find email | |
Prem Pavoor
Partner
|
Partner | Total investments: 8 | Find email | |
| See all 23 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
BlissClub
|
BlissClub is the community's first women's activewear brand. | $16.8M / Venture - Series Unknown / Aug 07, 2026 | |
Sonosemi Medical
|
Sonosemi Medical is a provider of medical devices that specializes in the development of pan-vascular active interventional products, diagnosis, and treatment solutions. | Series B / Jul 08, 2026 | |
Exponent Energy
|
Exponent Energy focuses on developing fast charging technology for electric vehicles.Exponent Energy's energy stack can speed up and simplify energy and charging for their client's electric vehicles which ensures the least amount of impedance buildup and results in a continuous flow of energy.The company also offers customers abattery management system, battery pack, and charger that all function in concert.Exponent Energy was established in 2020 by Arun Vinayak and Sanjay Byalal Jagannath in Bangalore, Karnataka. | $21M / Series B / Jun 10, 2026 | |
Immuneel Therapeutics
|
Immuneel Therapeutics Pvt Ltd is a pioneering startup company leading the charge in cell therapy and personalized immunotherapy for patients | $10.5M / Series B / Jun 08, 2026 | |
Tenpoint Therapeutics
|
Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics. | $85M / Series B / Jan 28, 2026 | |
AssetPlus
|
AssetPlus focuses on offering digital-first solutions to financial advisors and mutual fund distributors. | $19.3M / Series B / Jan 19, 2026 | |
Wint Wealth
|
GrowFix offers high net-worth individuals and retail investors, asset-backed fixed income products that offer higher returns than fixed deposits. | $27.7M / Series B / Jan 14, 2026 | |
Amenitiz
|
We created Amenitiz because we believe technology is the key to making success and profitability accessible to every hotelier in the world - whether they are in the heart of Paris or in the Uyuni Salt Flats in Bolivia. Our mission is to build an all-in-one platform to help owners grow and manage their vacation properties by making attractingguests, managing bookings and crafting exceptional experiences, simple and easy. We invite you to be part of our growing community and help us redefine the future of online hospitality together. | $45M / Series B / Nov 11, 2025 | |
ABK Biomedical
|
ABK Biomedical combines the clinical market with biomaterials. It specializes in improving treatment options for patients with hypervascular tumors. The company is dedicated to transforming an interventional radiology procedure called embolization. | $35M / Series D / Oct 14, 2025 | |
Safe Security
|
Safe Security offers a unified platform that quantifies and manages enterprise‑wide cyber risk in real time. It provides modules for Cyber Risk Quantification (CRQ), Third‑Party Risk Management (TPRM), Continuous Threat Exposure Management (CTEM), and support for cyber insurance processes. The platform aggregates automated signals across people,processes, technology, external threats, and vendors, and uses agent‑based AI to generate risk scores, projected financial impact, and prioritized actions. The solution delivers continuous monitoring, benchmarking, and risk reporting that aligns cybersecurity metrics with business objectives | $70M / Series C / Jul 31, 2025 | |
| See all 385 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Eight Roads Ventures invest in?
Eight Roads Ventures invests primarily in Software, Health Care and Information Technology startups, most often at Series B and Series A stage. Most of the 385 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Eight Roads Ventures's check size?
Eight Roads Ventures typically joins rounds of $6.5M–$62M at Series A, $8.5M–$85M at Series B and $15M–$118M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Eight Roads Ventures participates in.
How do I contact Eight Roads Ventures?
Public channels for Eight Roads Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Eight Roads Ventures?
The team at Eight Roads Ventures includes Aditya Systla (Partner), Gordon Zhang (Vice President & Principal) and Jarlon Tsang (Managing Partner, Head of China), among 23 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
